CA - Bausch files patent suit against Norwich over generic Xifaxan
2024-06-20 18:11:15 ET
More on Bausch Health Companies
- Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results
- Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript
- Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation
- Bausch issues update on Xifaxan patent dispute with Norwich
- Bausch Health Companies GAAP EPS of -$0.17, revenue of $2.15B